Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference
- Friday, September 11, 2020, 7:14
- PR Newswire
- Add a comment
LA JOLLA, Calif., Sept. 11, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (“Regulus”), today announced that Jay Hagan, President and Chief Executive Officer of…
About the Author
admin has written 20652 stories on this site.